Why are black men missing from prostate cancer research?

November 24, 2016, ecancer

Black men are three times more likely to develop prostate cancer than other demographics, yet black men are consistently underrepresented in research studies, say researchers from King's College London in a new paper published in ecancermedicalscience.

The problem? Healthcare research conducted in one demographic often doesn't translate to results for other demographics, and recruitment of ethnic minorities often fails to meet a balance.

For example, in 2015, realised that the HPV vaccines being given in the United States of America were less effective in African American women. The vaccines were developed for strains of the virus more commonly found in white women, on whom the clinical trials had been based.

Now, researchers warn that black men may not benefit from current research studies on prostate cancer.

"It's important that future research be generalizable," says study author Dr Mieke Van Hemelrijck of King's College London, London, UK. She explains that if black men don't participate in research studies, their unique needs and experiences will be missing from the conclusions.

To find out why this community is less likely to participate in research recruitment, the researchers surveyed the opinions and attitudes of sixteen black men undergoing treatment for prostate cancer in London.

"We uncovered a number of barriers to the recruitment of black men with prostate cancer into research studies," says Dr Van Hemelrijck.

These include mistrust of researchers and their motives, lack of understanding about the benefits and consequences of participating, and even a feeling in immigrant communities that traditional medicines and coping methods are more reliable.

So how can research studies on prostate cancer become more inclusive for ?

The researchers suggest that community-driven engagement may be the way forward, as well as dissemination of reliable information.

Hearing from black male survivors of may improve screening uptake as well as participation in research.

"There was mention of a mechanic who offered a free MOT to every black man who had received a prostate check at their GP surgery," says lead author Dr Charlotte Toms of King's College London, London, UK.

"When asked "do you think it helps the fact that he was a , who had been through it himself? And then he was then trying to engage people to come in?"An individual responded, "yes, yes. That helped.""

Explore further: Marker for aggressive prostate cancer doubles up as a drug target

More information: Charlotte Toms et al. Research engagement among black men with prostate cancer, ecancermedicalscience (2016). DOI: 10.3332/ecancer.2016.695

Related Stories

Marker for aggressive prostate cancer doubles up as a drug target

November 8, 2016
Researchers have discovered that a marker found on aggressive prostate cancer cells could also be used as a way to guide treatments to the cancer, according to new research presented at the National Cancer Research Institute ...

Black men are at double the risk of prostate cancer compared to white men

July 29, 2015
Black men in England are at double the lifetime risk of being diagnosed with, and dying from, prostate cancer compared with white men in England, according to research published in the open access journal BMC Medicine.

AUA: BRCA mutations may play role in prostate cancer

May 10, 2016
(HealthDay)—A man's risk of aggressive and fatal prostate cancer may be heavily influenced by gene mutations previously linked to breast and ovarian cancer in women, a trio of new studies suggests. Findings from the studies ...

Raised risk of prostate cancer in Black men

October 1, 2008
(PhysOrg.com) -- Black men living in England are three times more likely to get prostate cancer than White men and tend to be diagnosed five years younger, researchers have found.

Racial differences in outcomes, costs of care in older men with prostate cancer

October 22, 2015
Older black men with localized prostate cancer were more likely to have poorer quality care, incur higher costs and have worse postoperative outcomes than white men but that did not translate to worse overall or cancer-specific ...

Circumcision could prevent prostate cancer... if it's performed after the age of 35

April 7, 2014
Researchers at the University of Montreal and the INRS-Institut-Armand-Frappier have shown that men circumcised after the age of 35 were 45% less at risk of later developing prostate cancer than uncircumcised men.

Recommended for you

Student develops microfluidics device to help scientists identify early genetic markers of cancer

October 16, 2018
As anyone who has played "Where's Waldo" knows, searching for a single item in a landscape filled with a mélange of characters and objects can be a challenge. Chrissy O'Keefe, a Ph.D. student in the Department of Biomedical ...

A bad influence—the interplay between tumor cells and immune cells

October 16, 2018
Research at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) yielded new insights into the environment surrounding different types of lung tumors, and described how these complex cell ecosystems may in turn ...

Technique to 'listen' to a patient's brain during tumour surgery

October 16, 2018
Surgeons could soon eavesdrop on a patient's brain activity during surgery to remove their brain tumour, helping improve the accuracy of the operation and reduce the risk of impairing brain function.

Researchers elucidate roles of TP63 and SOX2 in squamous cell cancer progression

October 16, 2018
Squamous cell carcinomas (SCCs) are aggressive malignancies arising from the squamous epithelium of various organs, such as the esophagus, head and neck, lungs, and skin. Previous studies have demonstrated that two master ...

Function of neutrophils during tumor progression unraveled

October 15, 2018
Researchers at The Wistar Institute have characterized the function of neutrophils, a type of white blood cells, during early stages of tumor progression, showing that they migrate from the bone marrow to distant sites and ...

Delving where few others have gone, leukemia researchers open new path

October 15, 2018
A Wilmot Cancer Institute study uncovers how a single gene could be at fault in acute myeloid leukemia (AML), one of the deadliest cancers. The breakthrough gives researchers renewed hope that a gene-targeted therapy could ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.